David McGarry is an experienced researcher specializing in cancer biology, with a focus on posttranslational modifications, reactive oxygen species, and drug development. McGarry's professional journey includes roles as a Postdoctoral Research Assistant at the University of Freiburg and the University of Dundee, as well as a Postdoctoral Research Scientist at Cancer Research UK Beatson Institute. Currently serving as a Senior Research Scientist at AstraZeneca since September 2022, McGarry has developed transgenic mouse models, biochemical assays, and employed advanced techniques such as mass spectrometry and CRISPR. McGarry holds a Ph.D. in Toxicology from the University of Dundee and a BSc in Pharmacology from Newcastle University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices